Algonomics is a Belgium-based biotech company providing integrated
immunogenicity services to support companies in the development of
biotherapeutics. Algonomics’ broad range of services includes specialized
modeling, characterization and structure annotation studies for therapeutic
proteins and antibody-based therapeutics.
About Epibase and Epibase-IV
Epibase combines in silico
methodologies and in vitro assays to assess the immunogenicity of
biotherapeutics, such as therapeutic antibodies, biosimilars and vaccines.
While the computer based algorithms focus on lead selection and
optimization, the in vitro tests allow the comparison of lead formulations
and formats, by challenging donor derived cells with protein therapeutics.